Primary hyperaldosteronism due to adrenal microadenoma: A curable cause of refractory hypertension

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 9, Issue 2, 2008, Pages 103-106

  Myint, Khin Swe ^a   Watts, Michaela ^a   Appleton, Derris S ^a   Lomas, David J ^a   Jamieson, Neville ^a   Taylor, Kevin P ^a   Coghill, Stuart ^a   Brown, Morris J ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Adrenal microadenoma; Adrenal vein sampling; Hyper aldesteronism; Renin angiotensin

Indexed keywords

ALDOSTERONE; AMILORIDE; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BENDROFLUMETHIAZIDE; CANDESARTAN; HYDROCORTISONE; NIFEDIPINE; RENIN; SODIUM ION; SPIRONOLACTONE;

ADRENAL CORTEX ADENOMA; ADRENALECTOMY; ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; CASE REPORT; CHEMOLUMINESCENCE; COMPUTER ASSISTED TOMOGRAPHY; DRUG RESPONSE; DRUG WITHDRAWAL; FEMALE; HISTOPATHOLOGY; HOSPITAL DISCHARGE; HUMAN; HUMAN TISSUE; HYDROCORTISONE BLOOD LEVEL; HYPERTENSION; HYPOKALEMIA; LAPAROSCOPIC SURGERY; MALE; MICROADENOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMA RENIN ACTIVITY; POSTOPERATIVE PERIOD; PRIMARY HYPERALDOSTERONISM; ROBOTICS; SODIUM RETENTION; THERAPY RESISTANCE;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL ADENOMA; ALDOSTERONE; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD VESSELS; DRUG RESISTANCE; FEMALE; HUMANS; HYDROCORTISONE; HYPERALDOSTERONISM; HYPERTENSION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RENIN; TOMOGRAPHY, X-RAY COMPUTED;

EID: 47349110846     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.3317/jraas.2008.015     Document Type: Article

References (13)

1. Fogari R, Preti P, Zoppi A, Rinaldi A, Fogari E, Mugellini A. Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an aldosterone/renin ratio above 25 as a screening test. Hypertens Res 2007;30:111-17.
2. Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC. High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 1994;21:315-18.
3. Hood S, Cannon J, Foo R, Brown M. Prevalence of primary hyperaldosteronism assessed by aldosterone/renin ratio and spironolactone testing. Clin Med 2005;5(1):55-60.
4. de Bruin RA, Bouhuizen A, Diederich S, Perschel FH, Boomsma F, Deinum J. Validation of a new automated renin assay. Clin Chem 2004; 50:2111-16.
5. Hartman D, Sagnella GA, Chesters CA, Macgregor GA. Direct renin assay and plasma renin activity assay compared. Clin Chem 2004; 50:2159-61.
6. Derkx FH, de Bruin RJ, van Gool JM et al. Clinical validation of renin monoclonal antibody-based sandwich assays of renin and prorenin, and use of renin inhibitor to enhance prorenin immunoreactivity. Clin Chem 1996;42:1051-63.
7. Hartman D, Sagnella GA, Chesters CA, Macgregor GA. Direct renin assay and plasma renin activity assay compared. Clin Chem 2004; 50:2159-61.
8. Mulatero P, Dluhy RG, Giacchetti G, Boscaro M, Veglio F, Stewart PM. Diagnosis of primary aldosteronism: from screening to subtype differentiation. Trends Endocrinol Metab 2005;16:114-19.
9. Stowasser M, Gordon RD, Gunasekera TG et al. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients. J Hypertens 2003;21:2149-57.
10. Doppman JL, Gill JR Jr., Miller DL et al. Distinction between hyperaldosteronism due to bilateral hyperplasia and unilateral aldosteronoma: reliability of CT. Radiology 1992; 184:677-82.
11. Radin DR, Manoogian C, Nadler JL. Diagnosis of primary hyperaldosteronism: importance of correlating CT findings with endocrinologic studies. Am J Roentgenol 1992;158:553-7.
12. Ganguly A, Zager PG, Luetscher JA. Primary aldosteronism due to unilateral adrenal hyperplasia. J Clin Endocrinol Metab 1980; 51:1190-4.
13. Mansoor GA, Malchoff CD, Arici MH, Karimeddini MK, Whalen GF. Unilateral adrenal hyperplasia causing primary aldosteronism: limitations of I-131 norcholesterol scanning. Am J Hypertens 2002;15:459-64.